Shopping Cart
Remove All
Your shopping cart is currently empty
TargetMol Star Molecule—3-Methyladenine (Cat. No. T1879, CAS 5142-23-4), A Gold-Standard Tool for Autophagy Inhibition Studies
Background
3-Methyladenine (T1879) is a well-characterized inhibitor of phosphoinositide 3-kinases (PI3Ks), exhibiting selective inhibition of class IB PI3Kγ and class III VPS34 with IC50 values of approximately 60 μM and 25 μM, respectively. This dual specificity underpins its pivotal role in modulating autophagy, a cellular degradation pathway essential for maintaining cellular homeostasis and mitochondrial quality control through mitophagy. The class III PI3K VPS34 is a key enzyme responsible for generating phosphatidylinositol 3-phosphate (PI3P), a lipid signaling molecule critical for the nucleation of autophagosomal membranes. By inhibiting VPS34, 3-Methyladenine effectively suppresses the initiation of autophagy, thereby disrupting the formation of autophagosomes and subsequent lysosomal degradation of cellular components. Additionally, inhibition of PI3Kγ impacts signaling pathways involved in immune responses and inflammation, further influencing cellular dynamics.
Molecular Structure of 3-Methyladenine
In research contexts, 3-Methyladenine is extensively utilized as a pharmacological tool to dissect the molecular mechanisms governing autophagy and mitophagy. Its ability to selectively inhibit VPS34 allows researchers to delineate the role of PI3P production in autophagosome biogenesis and to investigate the downstream effects on cellular metabolism and survival under stress conditions. Moreover, by modulating PI3Kγ activity, 3-Methyladenine serves as a probe to explore the crosstalk between autophagy and immune signaling pathways. This compound’s utility extends to studies on endogenous metabolite regulation, given its structural similarity to adenine derivatives, enabling insights into nucleotide metabolism and signaling.
The dynamic interaction of 3-Methyladenine with the PI3K pathway highlights its importance in controlling autophagic flux. By inhibiting VPS34, 3-Methyladenine reduces PI3P levels, thereby impairing the recruitment of effector proteins necessary for autophagosome membrane elongation and closure. This blockade provides a mechanistic basis for studying autophagy-dependent processes such as mitophagy, where selective degradation of damaged mitochondria is crucial for cellular health. Consequently, 3-Methyladenine is instrumental in elucidating the balance between autophagy activation and inhibition, offering a valuable approach to understand how cells regulate degradation pathways in response to metabolic and environmental cues.
Overall, 3-Methyladenine (T1879) remains a cornerstone compound in autophagy research, enabling detailed exploration of PI3K-mediated signaling and its implications in cellular quality control mechanisms. Its selective inhibition profile facilitates targeted investigation into the molecular underpinnings of autophagy and mitophagy, providing a robust experimental framework for advancing knowledge in cell biology and pathophysiology without implying therapeutic use.
Literature review
2.1 Astrocytic SIRT1 ameliorates cognitive deficits after traumatic brain injury via autophagy-mediated MEGF10 phagocytosis
3-Methyladenine(T1879) was shown in the study to inhibit the autophagy process promoted by SIRT1 overexpression in astrocytes. Specifically, SIRT1 overexpression enhanced autophagy as evidenced by increased LC3-II/LC3-I ratio and BECLIN1 levels and decreased P62. This autophagic activation led to a reduction in the phagocytic receptor MEGF10 expression. However, the administration of 3-Methyladenine reversed these effects: it abrogated the SIRT1-induced enhancement of autophagy markers and restored MEGF10 protein levels to higher expression by inhibiting autophagic flux. Therefore, 3-Methyladenine primarily acted to block the promotion of autophagy by SIRT1, which in turn removed the suppression on MEGF10. These findings highlight that 3-Methyladenine interferes with the SIRT1-autophagy pathway that modulates astrocytic phagocytosis after brain injury, demonstrating its inhibitory role on autophagy and the downstream regulation of MEGF10 expression in the context of this study.[3]
2.2 USP20 governs tyrosine kinase inhibitors resistance through ferroptosis evasion by targeting GPX4 in cancers
In this study, 3-Methyladenine(T1879), identified as an autophagy inhibitor, was employed to evaluate its effect on cell viability following sorafenib treatment. Experimental findings demonstrate that 3-Methyladenine had minimal or no effect in rescuing cell viability in the context of sorafenib-induced cell death. Unlike ferroptosis inhibitors such as Ferrostatin-1, Liproxstatin-1, and Deferoxamine, which substantially rescued cell viability, 3-Methyladenine did not alter the susceptibility of cancer cells to sorafenib. These results underscore that in the studied model, 3-Methyladenine’s inhibition of autophagy does not play a discernible role in modulating sorafenib-induced cytotoxicity.[4]
2.3 Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death
In this study, 3-Methyladenine(T1879) acted as an autophagy inhibitor in the context of osimertinib-induced cellular changes. Specifically, treatment with 3-Methyladenine reduced the elevated protein levels of p62 and LC3-II, indicating suppression of autophagy activity. These proteins, p62 and LC3-II, are markers associated with the accumulation of autophagosomes triggered by osimertinib. Thus, application of 3-Methyladenine resulted in the inhibition of autophagic processes that were otherwise enhanced by osimertinib exposure.[5]
Reference
[1] 1. Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, Ong CN, Codogno P, Shen HM. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010;285(14):10850-61.
[2] 2. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem. 2000;275(2):992-8.
[3] Ji Q, Zhang Y, Zhang Z, Cui K, Zhao L, Sun X, et al.. Astrocytic SIRT1 ameliorates cognitive deficits after traumatic brain injury via autophagy-mediated MEGF10 phagocytosis. Journal of Neuroinflammation. 2025;22(1):.
[4] Wang Y, Liu B, Zhuang Y, Zhang Y, Dan W, Ding P, et al.. USP20 governs tyrosine kinase inhibitors resistance through ferroptosis evasion by targeting GPX4 in cancers. Redox Biology. 2026;92():104086.
[5] Qiu Y, Liu Y, Ding H, Xin W, Lu S, Hu Y, et al.. Osimertinib activates TFEB to trigger hepatocyte cytoplasmic vacuolation-associated cell death. Cell Communication and Signaling. 2026;24(1):.
Other Articles
Subscription to TargetMol News
An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.